Change search criteria ↓

Search results

1 677 projects found matching your search criteria:

  1. 1. Does the simulation as a teaching method affect pharmacy students' self-efficacy according to the Bandura theory?

    Principal investigator: Beata Maria Plewka

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: PRELUDIUM 20, Panel: HS6

  2. 2. Design, Synthesis and Characterization of Functionalized 1,2,4-Trioxanes/Trioxepanes for Antimalarial and Anticancer Use

    Principal investigator: dr Mohit Kumar Tiwari

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: SONATINA 7, Panel: NZ7

  3. 3. A new concept of inhibiting the progression of Alzheimer's disease based on the modification of the blood-brain barrier …

    Principal investigator: prof. Agnieszka Basta-Kaim

    Instytut Farmakologii PAN

    Call: OPUS 28, Panel: NZ4

  4. 4. The role of gut microbiota in the treatment of epilepsy: experimental studies

    Principal investigator: prof. Piotr Wiktor Wlaź

    Uniwersytet Marii Curie-Skłodowskiej w Lublinie

    Call: OPUS 27, Panel: NZ4

  5. 5. Theranostic oxygen nanobubbles for cancer radiotherapy enhancement and perfusion imaging

    Principal investigator: dr hab. Martyna Elas

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

    Call: OPUS 23, Panel: NZ4

  6. 6. New approach to the treatment of Alzheimer's disease targetingresolution of inflammation and modulation of biomechanical…

    Principal investigator: prof. Agnieszka Basta-Kaim

    Instytut Farmakologii PAN

    Call: OPUS 22, Panel: NZ4

  7. 7. Metabolic reprogramming in age-dependent endothelial dysfunction and vascular stiffness; novel mechanism of inflamm-agei…

    Principal investigator: prof. Stefan Karol Chłopicki

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

    Call: MAESTRO 13, Panel: NZ4

  8. 8. Investigating the role of the focal adhesion kinase and its related signaling pathways in glucocorticoid- and stress-ind…

    Principal investigator: Michał Józef Wilczkowski

    Instytut Farmakologii PAN

    Call: PRELUDIUM 20, Panel: NZ4

  9. 9. Spatial analysis of the effects of L-DOPA on gene expression in the prefrontal cortex in a mouse model of Parkinson's di…

    Principal investigator: dr Anna Aleksandra Radlicka-Borysewska

    Instytut Farmakologii PAN

    Call: PRELUDIUM 19, Panel: NZ4

  10. 10. The importance of the crosstalk between alpha-synuclein and sphingosine-1-phosphate-dependent signalling in experimental…

    Principal investigator: dr Joanna Agata Motyl

    Instytut Biocybernetyki i Inżynierii Biomedycznej im. Macieja Nałęcza PAN

    Call: SONATINA 3, Panel: NZ4

  11. 11. The role of epigenetic readers from BET family in the emergence and treatment of schizophrenia-like abnormalities in a n…

    Principal investigator: prof. Marzena Małgorzata Maćkowiak

    Instytut Farmakologii PAN

    Call: OPUS 16, Panel: NZ4

  12. 12. Role of angiotensin 1-12 and ACE-independent generation of Angiotensin II in peripheral endothelial dysfunction in heart…

    Principal investigator: Tasnim Mohaissen

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

    Call: PRELUDIUM 15, Panel: NZ4

  13. 13. Effects of adenosine P2Y12 receptors inhibition on central and peripheral chemoreceptors' sensitivity in humans

    Principal investigator: dr Stanisław Tubek

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Nauk o Zdrowiu

    Call: PRELUDIUM 14, Panel: NZ4

  14. 14. Interdisciplinary view on activity of coumarins on the central nervous system - behavioral, analytical and mode of actio…

    Principal investigator: prof. Krystyna Katarzyna Skalicka-Woźniak

    Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny

    Call: OPUS 14, Panel: NZ4

  15. 15. The influence of mitochondria-derived hydrogen sulfide (H2S) on the reprogramming of macrophages in atherosclerosis and …

    Principal investigator: dr Aneta Olga Stachowicz

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

    Call: SONATA 13, Panel: NZ4

  16. 16. In Search for the novel therapeutic strategies in the treatment of brain ischemia. Determination of the neuroprotective …

    Principal investigator: dr Bartosz Sebastian Pomierny

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: SONATA 11, Panel: NZ4

  17. 17. Influence of selected forms of graphene nanoparticle on isolated working hypertensive heart ex-vivo

    Principal investigator: prof. Marek Witold Radomski

    Kardio-Med Silesia Sp. z o.o.

    Call: OPUS 10, Panel: NZ4

  18. 18. Changes in neurogenesis during withdrawal from nicotine self-administration in rats - role of serotonin (5-HT)2C recepto…

    Principal investigator: dr Magdalena Joanna Zaniewska

    Instytut Farmakologii PAN

    Call: OPUS 9, Panel: NZ4

  19. 19. Pharmacotherapeutic mechanisms, spectroscopic signatures, and nanomechanics of dysfunctional endothelium in liver steato…

    Principal investigator: prof. Stefan Karol Chłopicki

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET); Pracownia Farmakologii Doświadczalnej Śródbłonka

    Call: SYMFONIA 3, Panel: NZ4

  20. 20. Analysis of changes in reward system activity during unpredictable stress in a model of less and more anxious animals - …

    Principal investigator: dr hab. Małgorzata Helena Lehner

    Instytut Psychiatrii i Neurologii

    Call: OPUS 8, Panel: NZ4

  21. 21. Pessimism as cognitive biomarker of depression in animal model

    Principal investigator: dr hab. Rafał Ryguła

    Instytut Farmakologii PAN

    Call: OPUS 7, Panel: NZ4

  22. 22. Influence of the chemical structure of coumarins derivatives on their central effects evaluated in behavioral and bichem…

    Principal investigator: dr Barbara Budzyńska

    Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny z Oddziałem Analityki Medycznej

    Call: OPUS 7, Panel: NZ4

  23. 23. Immunological biomarkers of drug resistant epilepsy and response to immunomodulatory therapy with ACTH in children

    Principal investigator: Magdalena Dorota Kaczorowska-Frontczak

    INSTYTUT - POMNIK - CENTRUM ZDROWIA DZIECKA

    Call: PRELUDIUM 6, Panel: NZ4

  24. 24. Neuronal and nonneuronal mechanisms of Bont/A effects in neuropathic pain development - behavioral and biochemical studi…

    Principal investigator: dr hab. Joanna Gabriela Mika

    Instytut Farmakologii PAN

    Call: HARMONIA 5, Panel: NZ4

  25. 25. The renin- angiotensin system in the breast cancer- in vitro study on metabolism and function of Angiotensin-(1-12).

    Principal investigator: dr Beata Agnieszka Bujak-Giżycka

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

    Call: OPUS 5, Panel: NZ4

  26. 26. Research on influence of antidepressant drugs on serum and brain levels of neurotrophins in rats, affected by the time d…

    Principal investigator: dr Maciej Sławomir Kuśmider

    Instytut Farmakologii PAN

    Call: OPUS 4, Panel: NZ4

  27. 27. Studies on the mechanism regulating expression of hormone-dependent cytochromes P450 in the rat liver under conditions o…

    Principal investigator: Rafał Andrzej Skowronek

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Lekarski w Katowicach

    Call: PRELUDIUM 4, Panel: NZ4

  28. 28. The effect of enriched environment on the epigenetic mechanism in neurodevelopmental model of schizophrenia.

    Principal investigator: dr Ewelina Bator

    Instytut Farmakologii PAN

    Call: PRELUDIUM 4, Panel: NZ4

  29. 29. Analysis of the anti-nociceptive and anti-inflammatory action of histamine H4 receptor antagonist in inflammatory nocice…

    Principal investigator: Przemysław Rzodkiewicz

    Instytut Reumatologii im. prof. dr hab. med. Eleonory Reicher

    Call: PRELUDIUM 2, Panel: NZ4

  30. 30. Search for biological background of diversified vulnerability to psychoactive substances in rats on the basis of ampheta…

    Principal investigator: dr hab. Ewa Taracha

    Instytut Psychiatrii i Neurologii

    Call: OPUS 2, Panel: NZ4

  31. 31. Histamine H3/H4 receptors as the attractive target for the search of biologically active substances

    Principal investigator: prof. Katarzyna Justyna Kieć-Kononowicz

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: MAESTRO 1, Panel: NZ4

  32. 32. The study of new synthetic triterpens anticancer activity at the level of autophagy induction and modulation of adhesion…

    Principal investigator: dr Natalia Magdalena Lisiak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

    Call: PRELUDIUM 1, Panel: NZ4

  33. 33. Modulations of DNA repair induced by anti cancer drugs by thiosugars

    Principal investigator: dr hab. Tomasz Popławski

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: OPUS 1, Panel: NZ4

  34. 34. Antiviral activity of novel acyclic phosphonate nucleoside analogues containing the 1,2,3-triazole moiety

    Principal investigator: dr Iwona Elżbieta Głowacka

    Uniwersytet Medyczny w Łodzi, Wydział Farmaceutyczny

    Call: SONATA 1, Panel: NZ4

  35. 35. Identification of cytochrome P450 isoenzymes involved in the metabolism of levomepromazine in the human

    Principal investigator: dr hab. Jacek Wójcikowski

    Instytut Farmakologii PAN

    Call: OPUS 1, Panel: NZ4

  36. 36. The effect of the lipoic acid nitroglycerin on the activity of aldehyde dehydrogenase. Impilication for broadening of ph…

    Principal investigator: prof. Lidia Włodek

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

    Call: OPUS 1, Panel: NZ4

  37. 37. The comparison of influence oleuropein and its dialdehydic derivative oleacein on functions of neutrophils

    Principal investigator: Monika Ewa Czerwińska (z d. Mańk)

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

    Call: PRELUDIUM 1, Panel: NZ4

  38. 38. Development of cellular models for the investigation of histamine H3 and H4 receptors pharmacology.

    Principal investigator: Tadeusz Piotr Karcz

    Uniwersytet Jagielloński- Collegium Medicum, Uniwersytet Jagielloński - Collegium Medicum; Wydział Farmaceutyczny z Oddziałem Analityki Medycznej

    Call: PRELUDIUM 1, Panel: NZ4

  39. 39. Synthesis and studies of reaction products of oxirane derivatives with the -NH-(C=)-Br functionality of heteroaromatic c…

    Principal investigator: dr Marzena Agnieszka Baran

    Uniwersytet Jagielloński- Collegium Medicum, Wydział Farmaceutyczny z Oddziałem Analityki Medycznej

    Call: PRELUDIUM 1, Panel: NZ4

  40. 40. Fluorinated analogues of marsanidine and 4-chloroindazim as potential PET radiotracers.

    Principal investigator: dr Aleksandra Wasilewska

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

    Call: OPUS 1, Panel: NZ4

  41. 41. In the search for active compounds among ligands of serotonin, particularly 5-HT7, and dopamine receptors, with potentia…

    Principal investigator: prof. Anna Małgorzata Wesołowska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 1, Panel: NZ4

  42. 42. Stilbene and stilbazole derivatives as potential cyclooxygenase-2 (COX-2) inhibitors with probable antitumor and chemopr…

    Principal investigator: Miłosz Jakub Regulski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

    Call: PRELUDIUM 1, Panel: NZ4

  43. 43. Evaluation of the protective capacity of resveratrol and quercetin in models of neurotoxicity induced by aluminum and ma…

    Principal investigator: dr Maciej Tadeusz Gawlik

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 1, Panel: NZ4

  44. 44. Search for compounds of anticancer activity in the group of polyphenolbenothiazinones and their derivatives

    Principal investigator: prof. Joanna Matysiak

    Uniwersytet Przyrodniczy w Lublinie, Wydział Nauk o Żywności i Biotechnologii

    Call: OPUS 1, Panel: NZ4

  45. 45. The new benzanilide derivates as promising anticancer agents

    Principal investigator: dr hab. Marek Arkadiusz Murias

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

    Call: OPUS 1, Panel: NZ4

  46. 46. Can extracts from Epilobium sp. inhibit proliferation of prostate cell LNCaP by influencing the activity of histone acet…

    Principal investigator: dr hab. Anna Karolina Kiss

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

    Call: SONATA 1, Panel: NZ4

  47. 47. Iron chelators- the novel approach to anticancer therapy

    Principal investigator: Maciej Michał Serda

    UNIWERSYTET ŚLĄSKI, Wydział Matematyki Fizyki i Chemii

    Call: PRELUDIUM 1, Panel: NZ4

  48. 48. Synthesis and marking the activity of new potential antagonists of receptors for excitatory amino acids which have the s…

    Principal investigator: prof. Aleksander Paweł Mazurek

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

    Call: OPUS 1, Panel: NZ4

  49. 49. Phenylpropanoid and terpenoid specialized metabolites in in vitro cultures of a valuable East Asian medicinal plant - Ag…

    Principal investigator: dr Sylwia Zielińska

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

    Call: PRELUDIUM 1, Panel: NZ4

  50. 50. Decoding signaling events inducing lipolysis in adipocytes during metabolic diseases

    Principal investigator: dr Grzegorz Sumara

    Instytut Biologii Doświadczalnej im. M. Nenckiego Polskiej Akademii Nauk

    Call: DIOSCURI 1, Panel: NZ4

Graphic design and implementation: Jakub Piotrowski